PDCD1 and neoplasm: In the subgroup of tumors with residual tumor after surgery a trend for better OS was seen for PD-1 expression (Agilent: p = 0.14, Figure 4B; Affymetrix: p = 0.11, not shown, significant for RNAseq: p = 0.036, not shown).